GlassScriptPhysician profile
Andrew W Mack
NPI 1063517175
$3,678.40
in general payments reported to CMS, 2019-2025
25 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $114 · 2021: $1,000 · 2022: $918 · 2023: $631 · 2024: $677 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198 · Travel and Lodging: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.47 |
| Travel and Lodging | $241.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,917.31 | 2019-2025 | Mako, Insignia |
| Zimmer Biomet Holdings, INC. | $685.68 | 2019-2024 | Persona |
| Ferring Pharmaceuticals INC. | $213.98 | 2022-2025 | Euflexxa |
| Solventum Corporation | $151.54 | 2024 | Prevena |
| Smith+Nephew, INC. | $114.85 | 2023-2024 | Journey II, Legion, Redapt |
| Innovation Technologies INC | $62.54 | 2022 | |
| Bioventus LLC | $58.46 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Prodigy Surgical Distribution, INC. | $48.65 | 2022 | |
| Depuy Synthes Sales INC. | $46.81 | 2021-2022 | |
| Heraeus Medical, LLC. | $45.14 | 2021-2022 | |
| Ibsa Pharma INC. | $39.40 | 2024 | Tirosint, Licart, Flector |
| Fidia Pharma USA INC. | $32.35 | 2023-2025 | Triluron, Hymovis |
| Pacira Pharmaceuticals Incorporated | $31.14 | 2022-2023 | Zilretta |
| Avanos Medical | $27.98 | 2023 | Grpro 2.1 |
| Abbott Laboratories | $24.36 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.56 | 2024 | Venaseal |
| Anika Therapeutics, INC. | $22.73 | 2021 | |
| Amgen INC. | $21.46 | 2021 | |
| Kci USA, INC. | $18.52 | 2022 | |
| Orthofix Medical, INC. | $17.70 | 2021 | |
| Davol INC. | $16.88 | 2022 | |
| Becton, Dickinson and Company | $15.00 | 2022 | |
| Dynasplint Systems INC. | $14.59 | 2024 | Dynasplint |
| Baudax Bio INC. | $14.22 | 2021 | |
| Endo USA, INC. | $13.55 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.